German Merck considers selling business of consumer-focused health

FRANKFURT/Cologne-the German Merck is considering selling your consumer driven health unit of 1 billion dollars to achieve their financial goals, after the decline in your liquid crystal business forced her to review your strategy.
The industry experts have regarded for years as the consumer-focused business whose brands include nutritional supplements Seven Seas and Bion and decongestant Nasivin-lacks critical scale.
Sources said the Administration polled informally potential buyers on several occasions over the years, only to be held back by the founding family, which still owns Merck 70% and favors a diversified strategy for the pharmaceuticals.
"We hope to increase the internal constraints to finance the deal to achieve the scale required. Anticipating that we''re completely preparing strategic options, "said the Chief Executive of the health business, Belen Garijo, in a statement.
"Any possible profit of a potential transaction would be used to meet the global financial goals of the company," added the Executive.
Merck predicted a stable profit of approximately 4.4 billion to 4.6 billion euros in your main core of business to 2017 and a mild to moderate organic increase in sales.